Survey of LDL-c Diameter and sdLDL-c Serum Levels in Relation with Hypertriglyceridemic waist Circumference Phenotype in Middle Aged Women

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 245

This Paper With 13 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ZUMS-23-97_001

تاریخ نمایه سازی: 11 اردیبهشت 1400

Abstract:

Background and Objectives: Obesity is a major risk factor of cardiovascular diseases. Visceral adipose tissue (VAT) plays an important role in complications obesity. Although the measurement of waist circumference is a useful index for evaluating obesity and its complications, always increasing of waist circumference is not associated with VAT accumulation. HTGW (Hypertriglyceridemic waist circumference) phenotype is a useful marker for visceral adipose tissue accumulation. The purpose of this study is comparison of sdLDL-c serum level and LDL-c particle size as risk factors for cardiovascular diseases in middle aged woman with HTGW phenotype and without it. Materials and Methods: For this purpose, ۹۰ volunteer women between ۴۰ and ۶۰ years old based on the four common definitions of HTGW phenotype, were divided into two groups with and without this phenotype. It was used precipitation method for measurement of serum levels of sdLDL-c. LDL-c particle size also was measured by the gradient gel electrophoresis technique. Results: Although in all of definitions, LDL-c particle size significantly was smaller in group with this HTGW phenotype, sdLDL-c serum level was statistical significant different in both definitions of HTGW-L and HTGW-H. Conclusion: According to significant difference in diameter of LDL-c particles and sdLDL-c concentrations grouped based on the definitions HTGW-L and HTGW-H as well as the role of sdLDL-c particles in cardiovascular diseases, therefore mentioned definitions are useful inexpensive screening tools to identify individuals at risk for cardiovascular diseases. References ۱- Després J-P. Cardiovascular disease under the influence of excess visceral fat. Critical Pathways In Cardiology. ۲۰۰۷ ۶: ۵۱-۹. ۲- Sarrafzadegan N, Kopaei SA. The Association between hypertriglyceridemic waist phenotype, menopause, and cardiovascular risk factors. Arch Iran Med. ۲۰۱۲ ۱۶: ۱۶۱-۶. ۳- Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. ۲۰۰۴ ۸۴: ۳۷۹: (۳)۷۹. ۴- Lemieux I, Poirier P, Bergeron J, et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol. ۲۰۰۷ ۲۳: ۲۳B-۳۱B. ۵- Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. ۱۹۹۸ ۲۸۰: ۱۸۴۳-۸. ۶- Hamdi O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. ۲۰۰۶ ۲: ۳۶۷-۷۳. ۷- Frayn KN. Visceral fat and insulin resistance causative or correlative? Br J of Nutr. ۲۰۰۰ ۸۳: S۷۱-S۷. ۸- Cornier M-A, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. ۲۰۰۸ ۲۹: ۷۷۷-۸۲۲. ۹- Leroith D. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type ۲ diabetes. Am J Med Sci. ۲۰۱۲ ۳۴۳: ۱۳-۶. ۱۰- Therond P. Catabolism of lipoproteins and metabolic syndrome. Curr Opin Clin Nutr Metab Care. ۲۰۰۹ ۱۲: ۳۶۶-۷۱. ۱۱- Superko HR, Gadesam RR. Is it LDL particle size or number that correlates with risk for cardiovascular disease? Curr Atheroscler rep. ۲۰۰۸ ۱۰: ۳۷۷-۸۵. ۱۲- Rizzo M, Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM. ۲۰۰۶۹۹:۱-۱۴. ۱۳- Gazi IF, Milionis HJ, Filippatos TD, et al. Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women. Diabetes Metab Res Rev. ۲۰۰۸ ۲۴: ۲۲۳-۳۰. ۱۴- Jellife DB .The assessment of the nutritional status of the Community. Monogr Set World Health. ۱۹۶۶: ۵۳: ۳-۲۷۱. ۱۵- Hirano T, Ito Y, Koba S,et al. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler, Thrombosis, Vasc biol. ۲۰۰۴ ۲۴: ۵۵۸-۶۳. ۱۶- Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. ۱۹۸۵ ۲۸: ۴۱۲-۹. ۱۷- Esteghamati A, Ashraf H, Esteghamati A-R, et al. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance. Diabetes Res Clin Pract. ۲۰۰۹ ۸۴: ۲۷۹-۸۷. ۱۸- Rainwater DL, Moore P, Shelledy W, Dyer TD, Slifer SH. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res. ۱۹۹۷ ۳۸: ۱۲۶۱-۶. ۱۹- Ghassab RK, Gohari LH, Firoozray M, Yegane MN. Determination of low density lipoprotein particle size by polyacrylamide gradient gel electrophoresis in patients with coronary artery stenosis. Lab Medicine. ۲۰۱۰ ۴۱: ۱۶۴-۶. ۲۰- Gazi IF, Filippatos TD, Tsimihodimos V, et al. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids. ۲۰۰۶ ۴۱: ۶۴۷-۵۴. ۲۱- Bos G, Dekker JM, Heine RJ. Non-HDL cholesterol contributes to the “Hypertriglyceridemic Waist” as a cardiovascular risk factor. The Hoorn study. Diabetes care. ۲۰۰۴ ۲۷: ۲۸۳-۴. ۲۲- Nikolic D, Katsiki N, Montalto G, Isenovic ER, Mikhailidis DP, Rizzo M. Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients. ۲۰۱۳ ۵: ۹۲۸-۴۸. ۲۳- Group UPDS. UK prospective diabetes study ۲۷: plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes care. ۱۹۹۷ ۲۰: ۱۶۸۳-۷. ۲۴- Hosseini Gohari L, Karimzadeh Ghassab R, Firoozray M, Zavarehee A, Basiri HA. The association between small dense low density lipoprotein, apolipoprotein B, apolipoprotein B/apolipoprotein A۱ ratio and coronary artery stenosis. Med J I.R.Iran. ۲۰۰۹ ۲۳: ۸-۱۳.

Authors

مهدی بهمنی

Zanjan Metabolic Disease Research Center and Biochemistry Dept, Zanjan University of Medical Sciences, Zanjan, Iran

سپیده سخنور

Dept of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran

سعیده مظلومزاده

Zanjan Metabolic Disease Research Center and Biochemistry Dept, Zanjan University of Medical Sciences, Zanjan, Iran

اکرم ملکی

Zanjan Metabolic Disease Research Center and Biochemistry Dept, Zanjan University of Medical Sciences, Zanjan, Iran

علی ملتی

Zanjan Metabolic Disease Research Center and Biochemistry Dept, Zanjan University of Medical Sciences, Zanjan, Iran